Cargando…

Weight Monitoring and Antipsychotics: Are We Compliant With NICE Guidelines?

AIMS: To improve Antipsychotic weight monitoring for patients within the Homeless Outreach (START) team. METHODS: All adult patients accepted by the START team (Lambeth, Southwark, and Croydon locations) between June and October 2022 that had been initiated on Antipsychotic medication were identifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Byrone, Chivers, Gary, Drife, Jenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345314/
http://dx.doi.org/10.1192/bjo.2023.100
_version_ 1785073059732914176
author Mitchell, Byrone
Chivers, Gary
Drife, Jenny
author_facet Mitchell, Byrone
Chivers, Gary
Drife, Jenny
author_sort Mitchell, Byrone
collection PubMed
description AIMS: To improve Antipsychotic weight monitoring for patients within the Homeless Outreach (START) team. METHODS: All adult patients accepted by the START team (Lambeth, Southwark, and Croydon locations) between June and October 2022 that had been initiated on Antipsychotic medication were identified retrospectively (n = 11). 1. Was there compliance with NICE weekly weight monitoring (for the first 6 weeks) following Antipsychotic initiation? 2. Was weight measured at least once following Antipsychotic initiation? 3. Was a Physical Health Screen documented following Antipsychotic initiation? RESULTS: During the audit period a total of 56 patients were accepted by the START team. Of these 11 (20%) were initiated on Antipsychotic medication. 0 patients had weekly weight monitoring compliant with NICE guidelines. 0 patients had their weight measured at least once following Antipsychotic initiation. A Physical Health screen was documented for 4 (36%) patients following Antipsychotic initiation. CONCLUSION: 1. The following interventions were implemented: 2. To address staff awareness, START team members were given a presentation on the importance of Antipsychotic monitoring and current NICE guidelines. 3. An alert will be added to patient notes (ePJS) on initiation of Antipsychotic medication to remind staff to carry out required weight monitoring. 4. Portable weighing scales were purchased for the team to ensure patients’ weight can be measured on outreach reviews.
format Online
Article
Text
id pubmed-10345314
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-103453142023-07-15 Weight Monitoring and Antipsychotics: Are We Compliant With NICE Guidelines? Mitchell, Byrone Chivers, Gary Drife, Jenny BJPsych Open Rapid-Fire Presentations AIMS: To improve Antipsychotic weight monitoring for patients within the Homeless Outreach (START) team. METHODS: All adult patients accepted by the START team (Lambeth, Southwark, and Croydon locations) between June and October 2022 that had been initiated on Antipsychotic medication were identified retrospectively (n = 11). 1. Was there compliance with NICE weekly weight monitoring (for the first 6 weeks) following Antipsychotic initiation? 2. Was weight measured at least once following Antipsychotic initiation? 3. Was a Physical Health Screen documented following Antipsychotic initiation? RESULTS: During the audit period a total of 56 patients were accepted by the START team. Of these 11 (20%) were initiated on Antipsychotic medication. 0 patients had weekly weight monitoring compliant with NICE guidelines. 0 patients had their weight measured at least once following Antipsychotic initiation. A Physical Health screen was documented for 4 (36%) patients following Antipsychotic initiation. CONCLUSION: 1. The following interventions were implemented: 2. To address staff awareness, START team members were given a presentation on the importance of Antipsychotic monitoring and current NICE guidelines. 3. An alert will be added to patient notes (ePJS) on initiation of Antipsychotic medication to remind staff to carry out required weight monitoring. 4. Portable weighing scales were purchased for the team to ensure patients’ weight can be measured on outreach reviews. Cambridge University Press 2023-07-07 /pmc/articles/PMC10345314/ http://dx.doi.org/10.1192/bjo.2023.100 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. This does not need to be placed under each abstract, just each page is fine.
spellingShingle Rapid-Fire Presentations
Mitchell, Byrone
Chivers, Gary
Drife, Jenny
Weight Monitoring and Antipsychotics: Are We Compliant With NICE Guidelines?
title Weight Monitoring and Antipsychotics: Are We Compliant With NICE Guidelines?
title_full Weight Monitoring and Antipsychotics: Are We Compliant With NICE Guidelines?
title_fullStr Weight Monitoring and Antipsychotics: Are We Compliant With NICE Guidelines?
title_full_unstemmed Weight Monitoring and Antipsychotics: Are We Compliant With NICE Guidelines?
title_short Weight Monitoring and Antipsychotics: Are We Compliant With NICE Guidelines?
title_sort weight monitoring and antipsychotics: are we compliant with nice guidelines?
topic Rapid-Fire Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345314/
http://dx.doi.org/10.1192/bjo.2023.100
work_keys_str_mv AT mitchellbyrone weightmonitoringandantipsychoticsarewecompliantwithniceguidelines
AT chiversgary weightmonitoringandantipsychoticsarewecompliantwithniceguidelines
AT drifejenny weightmonitoringandantipsychoticsarewecompliantwithniceguidelines